Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
8.50T | 8.38T | 7.39T | 6.70T | 7.49T | Gross Profit |
2.49T | 2.26T | 2.08T | 1.97T | 2.15T | EBIT |
390.00B | 288.57B | 357.53B | 258.60B | 293.75B | EBITDA |
845.50B | 718.31B | 731.06B | 615.19B | 698.09B | Net Income Common Stockholders |
443.99B | 265.50B | 255.33B | 165.08B | 225.71B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.35T | 989.16B | 1.42T | 1.74T | 1.16T | Total Assets |
9.41T | 8.06T | 8.02T | 6.85T | 6.22T | Total Debt |
1.63T | 1.46T | 1.90T | 1.45T | 1.47T | Net Debt |
506.65B | 637.61B | 691.41B | -145.80B | 454.81B | Total Liabilities |
4.69T | 4.27T | 4.68T | 4.08T | 4.06T | Stockholders Equity |
4.54T | 3.62T | 3.16T | 2.59T | 2.00T |
Cash Flow | Free Cash Flow | |||
219.70B | 150.86B | -45.15B | 207.61B | 85.02B | Operating Cash Flow |
866.90B | 520.74B | 252.63B | 504.04B | 430.30B | Investing Cash Flow |
-591.88B | -344.03B | -796.15B | 176.60B | -206.10B | Financing Cash Flow |
-70.46B | -607.01B | 58.91B | -177.70B | 48.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥22.80T | 19.98 | 14.40% | 0.52% | 9.56% | 26.52% | |
77 Outperform | $16.77T | 27.44 | 10.50% | 1.06% | 0.56% | 5.32% | |
75 Outperform | €5.91T | 18.05 | 8.40% | 1.82% | 5.02% | 14.73% | |
73 Outperform | ¥5.80T | 26.08 | 11.70% | 0.85% | -5.48% | -11.96% | |
70 Outperform | ¥3.94T | 11.82 | 7.23% | 2.19% | 1.72% | -33.60% | |
60 Neutral | $10.94B | 10.58 | -7.08% | 2.98% | 7.52% | -12.04% | |
44 Neutral | ¥553.75B | ― | ― | -5.57% | 38.15% |